Correlation Between Arrowhead Pharmaceuticals and ATRYS HEALTH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and ATRYS HEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and ATRYS HEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals and ATRYS HEALTH SA, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and ATRYS HEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of ATRYS HEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and ATRYS HEALTH.

Diversification Opportunities for Arrowhead Pharmaceuticals and ATRYS HEALTH

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Arrowhead and ATRYS is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and ATRYS HEALTH SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATRYS HEALTH SA and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with ATRYS HEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATRYS HEALTH SA has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and ATRYS HEALTH go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and ATRYS HEALTH

Assuming the 90 days trading horizon Arrowhead Pharmaceuticals is expected to generate 2.63 times more return on investment than ATRYS HEALTH. However, Arrowhead Pharmaceuticals is 2.63 times more volatile than ATRYS HEALTH SA. It trades about 0.16 of its potential returns per unit of risk. ATRYS HEALTH SA is currently generating about 0.08 per unit of risk. If you would invest  1,747  in Arrowhead Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of  363.00  from holding Arrowhead Pharmaceuticals or generate 20.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Arrowhead Pharmaceuticals  vs.  ATRYS HEALTH SA

 Performance 
       Timeline  
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
ATRYS HEALTH SA 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Arrowhead Pharmaceuticals and ATRYS HEALTH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arrowhead Pharmaceuticals and ATRYS HEALTH

The main advantage of trading using opposite Arrowhead Pharmaceuticals and ATRYS HEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, ATRYS HEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATRYS HEALTH will offset losses from the drop in ATRYS HEALTH's long position.
The idea behind Arrowhead Pharmaceuticals and ATRYS HEALTH SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation